William D. Gwynne

Cancer-selective metabolic vulnerabilities in MYC-amplified medulloblastoma

William D. Gwynne, Yujin Suk, Stefan Custers et al. · Cancer Cell · 2022 · 98 citations

Medicine, Cancer Biology, Oncology +14

CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment

Mathieu Seyfrid, William Maich, Muhammad Vaseem Shaikh et al. · Journal for ImmunoTherapy of Cancer · 2022 · 79 citations · Full text

Medicine, Immunology, Oncology +17

Serotonergic system antagonists target breast tumor initiating cells and synergize with chemotherapy to shrink human breast tumor xenografts

William D. Gwynne, Robin Hallett, Adele Girgis-Gabardo et al. · Oncotarget · 2017 · 52 citations · Full text

Medicine, Oncology, Pharmacology +13

Serotonin transporter antagonists target tumor-initiating cells in a transgenic mouse model of breast cancer

Robin Hallett, Adele Girgis-Gabardo, William D. Gwynne et al. · Oncotarget · 2016 · 33 citations · Full text

Medicine, Oncology, Pharmacology +16

The proteomic landscape of glioblastoma recurrence reveals novel and targetable immunoregulatory drivers

Nazanin Tatari, Shahbaz Khan, Julie Livingstone et al. · Acta Neuropathologica · 2022 · 32 citations · Full text

Medicine, Cancer Biology, Oncology +16